Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 600 clinical trials
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer

This is a large, prospective, single-arm cohort study of transvaginal ultrasonographic screening for ovarian cancer in intermediate to high-risk women from Kentucky. Detection of ovarian

cancer of the ovary
breast cancer
  • 0 views
  • 25 Jul, 2021
  • 1 location
D9319C00001- 1L OC Mono Global RCT

participants with Stage III to IV high grade serous or endometroid ovarian cancer (including fallopian tube cancer or primary peritoneal cancer) who are in complete or partial response following treatment with

cancer chemotherapy
bevacizumab
platinum-based chemotherapy
interval debulking surgery
cancer antigen 125
  • 0 views
  • 22 Jul, 2021
  • 82 locations
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

stage III epithelial ovarian cancer randomizing between primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy

fallopian tube
ovarian epithelial carcinoma
cancer chemotherapy
cytoreductive surgery
intraperitoneal chemotherapy
  • 0 views
  • 12 Jun, 2021
  • 1 location
A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for women with BRCA1 mutations

oophorectomy
BRCA1
ovarian cancer
cancer
cancer antigen 125
  • 52 views
  • 03 Feb, 2021
  • 91 locations
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

high and low grade epithelial ovarian cancer (including fallopian tube and primary peritoneal cancer) and subsequent primary treatment surgery and chemotherapy. Half of the participants will receive to

cancer chemotherapy
platinum-based chemotherapy
ovarian epithelial carcinoma
ovarian cancer
tumor debulking
  • 0 views
  • 02 Jul, 2021
  • 20 locations
Hysterectomy and OPPortunistic SAlpingectomy

>implies reduced risk of subsequent ovarian cancer Randomization and follow-up will be conducted within national registers.

cancer of the ovary
laparotomy
  • 10 views
  • 26 Jan, 2021
  • 1 location
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

The goal of this clinical research study is to evaluate a method involving a blood test, called CA-125, that may be helpful in the early detection of ovarian cancer in women who are at low risk

cancer chemotherapy
cancer of the ovary
cancer antigen 125
  • 1609 views
  • 23 Jan, 2021
  • 11 locations
Effect of Tumor Treating Fields (TTFields 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)

of recurrent ovarian cancer . The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields or TTF) to the region of the

recurrent ovarian cancer
fallopian tube
cancer of the ovary
paclitaxel
carcinoma
  • 273 views
  • 25 Jul, 2021
  • 132 locations
Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients

ICON 9 will assess the efficacy, safety and tolerability of maintenance olaparib in combination with cediranib compared to maintenance olaparib alone following a response to platinum-based chemotherapy in women with relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer. Prognostic and predictive factors will be studied from tumour and blood samples.

olaparib
peritoneal cancer
cancer of the ovary
bevacizumab
carcinoma
  • 392 views
  • 15 Jul, 2021
  • 46 locations
Urinary Human Papilloma Virus Test in the General Population in Brittany

This is a population-based, prospective, multicenter and open-label study. 12,500 female non-respondents to the uterine cervix smear from 30 to 65 years of age in the context of the organized cervical cancer screening of the uterus, in the 4 Breton departments, will be proposed after stratification by age and socio-economic …

  • 0 views
  • 13 May, 2021
  • 1 location